FDA expands Merck antibiotic indication to pneumonia treatment

The previously FDA-approved drug, Zerbaxa, is now indicated for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news